Introduction
It is now generally accepted that competent host defence mechanisms can be an important determinant in the outcome of an individual's response to neoplastic disease. Current evidence suggests that human malignancies contain specific antigens, and that the major part of the host's response against a tumour involves the delayed hypersensitivity immune reaction, mediated by T-cell lymphocytes. The immune status of patients with carcinomas of the head and neck has accordingly been extensively investigated in recent years, in an attempt to define parameters which could be of prognostic value.
Various immunological abnormalities have been documented. Impairment of cell-mediated immunity has been inferred in vivo by unresponsiveness to recall antigens, e.g. tuberculin purified protein derivative (PPD), Candida albicans, mumps and trichophytin, and anergy to 2,4-dinitrochlorobenzene (DNCB), an industrial chemical and potent allergen (Eilber & Morton 1970 , Maisel & Ogura 1973 , Eilber et al. 1974 , Lundy et al. 1974 , Mandel & Kiehn 1974 , Twomey et al. 1974 , Parker et al. 1975 , Wanebo et al. 1975 , Pinsky et al. 1976 , Tanner et al. 1978 . Abnormal quantitative (Maisel & Ogura 1973 , Lee et al. 1975 , Wanebo et al. 1975 , Stephani et al. 1976 ) and qualitative (Catalona et al. 1973 , Eilber et al. 1974 , Twomey et al. 1974 , Parker et al. 1975 , Wanebo et al. 1975 , Jenkins et al. 1976 ) in vitro lymphocyte studies have also been reported.
The significance of most of these immunological abnormalities remains uncertain. However, absence of delayed cutaneous hypersensitivity to DNCB has been reported as a highly significant adverse prognostic factor in a number of studies of patients with squamous cell carcinoma involving the head and neck (Eilber & Morton 1970 , Maisel & Ogura 1973 , Lundy et al. 1974 , Mandel & Kiehn 1974 , Twomey et al. 1974 , Wanebo et al. 1975 , Pinsky et al. 1976 , Tanner et al. 1978 Patients with head and neck malignancies may present with concurrent nutritional deficiencies. Dysphagia, secondary to tumour involvement of the upper gastrointestinal tract with resulting pain or organic obstruction, is an important cause. These patients may suffer from anorexia, are frequently elderly, and may have a history of chronic alcohol abuse. All these factors can cause an inadequate dietary intake and lead to a nutritional deficit. In addition, tumour necrosis, ulceration, associated infection and haemorrhage, all result in an increased loss of protein (Chernow & Castell 1979) . A cachexia syndrome, probably resulting from a complex metabolic effect (Theologides 1972 (Theologides , 1979 , is well recognized in association with a wide range of malignancies, and may coexist in patients with head and neck tumours.
Methods
From March 1979 to February 1980, a prospective study into the nutritional status and general immune competence of 53 patients, presenting to the Head & Neck Oncology unit at King's College Hospital, was undertaken. Forty-six were 'new' cases with primary untreated carcinomas, whilst 7 cases presented with recurrent local or metastatic cervical lymph node disease. Histologically all tumours were squamous cell carcinomas. Table I shows the tumour site and TNM classification of the 'new' patients. It can be seen • Only patient with metastatic disease Classification: nasal sinuses, Lederman (1969) ; other sites, TNM (1978) that there is a predominance of patients with advanced disease. Of the patients with recurrent tumours, 3 cases occurred in the oral cavity and the other 4 in the cervical lymph nodes. Forty-seven per cent of the patients were over 65 years of age, and 26% were over 70 years.
General immune status
General immune status was assessed by delayed hypersensitivity skin tests with ONCB antigen, with recall antigens, together with serial total lymphocyte counts and serum immunoglobulin levels.
The ONCB sensitization and testing technique employed was that described by Catalona et al. (1972a) . This had been found to sensitize more than 96% of 143 normal individuals divided equally between the age range of 20-80 years. Catalona et al. (1972b) recorded an association between anergy to ONCB and increasing age; this did not, however; attain statistical significance. A large study by Bolton (1975) has not confirmed these age-related differences.
Following skin cleansing with acetone, 2000llg ONCB dissolved in 0.1 ml acetone was applied to the left volar forearm inside a 2 em diameter ring. The solution was allowed to evaporate, and the area occluded. In a similar fashion 50 ug ONCB was applied to the right forearm. At 48 hours the responses were observed. An irritative reaction at the 2000 ug dose test site only confirmed the integrity of the individual's general inflammatory response. An additional area of erythema at the 50llg site indicated previous sensitization, thereby invalidating the test.
At least 5 methods exist for interpreting the ONCB skin test (Bates et al. 1979) . The assessment of the responses in this study was based on the quantitative method described by Catalona et al. (l972b) . On day 14 both exposure sites were examined for a spontaneous flare reaction, consisting of erythema and a distinct margin of induration to the residual ONCB remaining in the skin. A spontaneous flare at both the 2000 ug and 50 ug sites was graded 5+ ; a flare at only the 2000 ug site was graded 4 +. In the absence of any reaction a challenge dose of 50 ug of ONCB was applied to the right forearm. This site was then examined at 48 hours for evidence of a delayed cutaneous hypersensitivity reaction, characterized by both erythema and induration. A reaction greater than 50% of the test area was graded 3+, and less than 50% 2 +. Erythema only, covering less than 50% of the test area, without induration and no response were both classed as anergic reactions, but recorded separately. Because the test took a minimum of 16 days to complete, only 15% of the patients had their ONCB status assessed before treatment commenced. In three-quarters of the cases, however, this assessment was achieved within the first two weeks of therapy.
The two skin test recall antigens used were tuberculin purified protein derivative (PPO) 5000 units in 0.1 ml (Evans Medical Ltd), and 0.1 ml of a I% Candida a/bieans antigen solution (Bencard Ltd). These were injected intradermally into the upper lateral aspect of the arm, and the resulting area of induration was recorded at 48 hours. The diameter of the indurated area was measured in two planes at 90°to each other, and an average value obtained. The responses were graded as follows: < 5 mm anergic; 5-10 mm I +; 10-15 mm 2 +; 15-20 mm 3 +; > 20 mm 4 +. A score of 2 + or greater was considered a normal response (Bates et al. 1979) . A positive response presupposed previous sensitization to the common antigen used.
Serum IgG, IgA and IgM immunoglobulins were assayed by the laser nephelometry technique.
Nutritional status
There is no one single parameter which can be used as an accurate indicator of nutritional status. Instead, various direct and indirect assessments of the body's protein stores must be made. These protein stores can be considered as two compartments; the somatic or muscle protein compartment, and the visceral compartment, which contains all other protein. Table 2 lists the parameters described and evaluated by Jelliffe (1966) , Bistrian et al. (1974 Bistrian et al. ( , 1975 , Blackburn et al. (1977) Blackburn & Bothe (1978) and Kaminski & Winborn (1978.) , which were used to assess general nutritional status. The 24-hour nitrogen excretion provides an indication of the rate of body protein catabolism, and is therefore an indirect index of the total protein stores.
All patients who were admitted to hospital for initial diagnostic endoscopy, general medical assessment or treatment, were weighed daily. The patients' current weight was then obtained by averaging at least three serial body weight measurements in almost all cases. The weight loss was then expressed as a percentage of the premorbid weight (P%), and as a percentage of the ideal weight in relation to height 0%).
Anthropometric indices were obtained by measuring the arm circumference at the midpoint of the upper non-dominant arm. Triceps skinfold thickness was measured at the same site with skin calipers, giving an index of the subcutaneous fat stores. These data were recorded in all cases by the same observer (GBB). The arm muscle circumference was derived by the formula: arm muscle circumference = mid-arm circumference -(n x triceps skinfold thickness). The deficit from the standard value (Jelliffe 1966) was then expressed as a percentage (A%).
Serum albumin was measured by the bromocresol green dye binding technique, and serum transferrin by the radial immunodiffusion method.
Results
In this study, weight loss and anthropometric measurements were found to give the most consistent and reproducible nutritional status data. These results were averaged to provide a general nutritional status score (GNSS): GNSS = P"1o+1%+A% 3 A GNSS of < -10% was considered to indicate a significant nutritional deficit.
Twenty-four hour urinary assays of creatinine and nitrogen often showed substantial daily variations. The creatinine height index values did not correlate well with weight and anthropometric data. Table 3 compares the GNSS of patients with reduced visceral protein parameters. Low albumen and transferrin values were, in general, only recorded in patients in relatively severe nutritional deficit, but not always consistently.
Analysis of the results has demonstrated a strong positive correlation between the nutritional status, as assessed by the GNSS, and the delayed hypersensitivity response to DNCB, which is statistically highly significant, (X 2 = 21.5, P < 0.005). In Figure 2 the nutritional status is compared with the four grades of initial DNCB reactivity and the two grades of anergy. Some of the patients were obese and consequently had high positive nutritional scores, whilst those with very low scores were in severe nutritional deficit. It can be seen that the nutritional deficit of the 20 patients who were anergic to DNCB was greater than 9.5% in all but one case. Conversely, except for two patients, none of those who demonstrated a positive response to DNCB suffered from a deficit of greater than 10.8%. These two patients had both received nutritional support by enteral hyperalimentation for periods of 22 and 29 days. Despite weight and anthropometric deficits, their biochemical nutritional parameters were normal. It seems likely that nutritional therapy was directly responsible for these two positive responses to DNCB. Two others were sensitive to DNCB from previous exposure, and were consequently excluded. Because only 15% of the patients had their immune status determined before commencing treatment, one must consider the possible effect of additional weight loss, occurring as a result of therapy, on DNCB reactivity. In the DNCB-reactive group the average time from commencing treatment to DNCB assessment was 15.8 days (range 0-43), and the mean variation in the GNSS was only -0.41% (range -4.0% to +3.2%). In the DNCB-anergic patients the average time from starting treatment to DNCB assessment was 24.3 days (range 0-57), and the mean variation in GNSS during this period was -2.6% (range -13.9% to + 1.4%). Two patients, one from each group, who were assessed following a 3-month treatment period were excluded from this analysis. Thus, there was no significant increased nutritional deficit caused by treatment in the vast majority of patients whose DNCB status was not obtained prior to commencing therapy.
Eighteen of the patients underwent subsequent DNCB testing either towards the end of or following primary treatment. This invariably consisted of radiotherapy alone, or combined
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Itatul • (%) .. .. . . ------r ------·----------- with cytotoxic chemotherapy. In Figure 3 the nutritional status is compared with both initial and subsequent DNCB reactivity or anergy. These subsequent test results were entirely consistent with initial DNCB reactivity, indicating no significant effect on DNCB reactivity by either treatment modality. In addition, 4 further instances of positive DNCB reactivity folIowing enteral hyperalimentation in significantly malnourished patients occurred. Table 4 presents the relationship of DNCB status to disease stage, age and sex. The ages and sex ratios are very similar between the groups. Consideration of the advanced disease stages, TJN o , T 3N 1 , T 4N o and To-4N2 -3 , reveals that 50% of these patients were reactive to DNCB, so that a clear association between advanced disease and DNCB anergy does not exist.
In this study, as in previously reported studies (Lundy et al. 1974 , Wanebo et al. 1975 , Parker et al. 1975 , Tanner et al. 1978 , anergy to DNCB did not correlate well with anergy to the skin test recall antigens PPD and Candida albicans. A negative correlation between DNCB and recall antigen reactivity was found in 35% of the 40 cases where a valid comparison could be made. It is possible that these differences resulted from the variable effects of therapy on A statistically highly significant correlation between pretreatment low peripheral lymphocyte count levels ( < l500/~I) and nutritional deficit ( > -10%) was also found (;(2 = 10.6, P < 0.005).
There were no significant differences in serum immunoglobulin levels in relation to nutritional status, and no correlation with the other tests of general immune status.
Discussion
In view of the positive correlation with anergy to DNCB, a widely accepted test of adverse prognostic value, we suggest that nutritional deficit is therefore probably also a significant adverse prognostic factor in patients with malignant disease of the head and neck. The assessment of nutritional status may enable a 'poor prognosis' group to be defined at the time of clinical presentation. It may be that clinical trials should classify and randomize patients by nutritional deficit, as well as by the more traditional disease parameters, such as tumour site, stage, histological differentiation and the presence or absence of lymph node involvement.
Studies of the immune status in individuals suffering from protein calorie malnutrition in the 'underdeveloped' countries have demonstrated significant immunoincompetence by both in vivo skin tests and in vitro assessment of lymphocyte function. This impaired immunity has been improved and in some cases converted to normal by adequate nutritional repletion (Geefhuysen et al. 1971 , Smyth et al. 1971 , Edelman et al. 1973 , Chandra 1974 . Law et al. (1974) comprehensively reviewed existing data on the effects of protein and calorie .malnutrition on immune competence in both man and animals. Improvement in certain immunological parameters has been demonstrated following intravenous hyperalimentation in malnourished adults (Law et al. 1973 , Copeland et al. 1976 ). In the present series the positive DCNB reactivity of patients in severe nutritional deficit following enteral hyperalimentation is consistent with these previous studies.
Nutritional support for any malnourished patient with malignant disease may also improve response to treatment by conferring greater tolerance to radiotherapy or cytotoxic chemotherapy, thus allowing more treatment to be given, or alternatively may reduce morbidity following surgery. Controlled studies are required to evaluate whether nutritional repletion of significantly malnourished patients with head and neck malignancies will improve their ultimate prospect of 'cure'.
Low lymphocyte counts have been reported as unfavourable prognostic indices in patients with malignant disease, notably of the head and neck (Maisel & Ogura 1973 , Lee et al. 1975 , and bronchus (Krant et al. 1968 , Riesco 1970 . The direct correlation between lymphocytopenia and poor nutritional state in this study adds some additional support to the adverse prognostic value of significant nutritional deficit.
Furthermore, consideration of the mechanism of DNCB sensitization indicates that this may be as much a test of nutritional status as of immunocompetence. Experimental work reviewed by Bolton (1975) has demonstrated that the DNCB delayed hypersensitivity reaction is mediated by sensitized lymphocytes. DNCB forms a hapten with skin protein when topically applied, and is believed to conjugate with a carrier protein in order to become immunogenic. As sensitization follows application of DNCB to the skin, it is presumed that the carrier protein is a component of normal skin. General nutritional deficit may be associated with both a reduction of epidermal protein, and with a quantitative or qualitative reduction of the appropriate specific carrier protein. An abnormality at either of these sites may thus block the afferent limb of the cell-mediated immune response to DNCB. In short, it is concluded that adequate nutritional status may be the rate-limiting factor in the DNCB sensitization test.
We therefore suggest that nutritional deficiency may be the primary adverse prognostic factor in patients with head and neck cancer, and that immunoincompetence may be a secondary phenomenon.
Although the maximum post-treatment follow-up period is only 12 months, 13 patients in the group with a nutritional deficit of greater than 10% are dead, 4 have recurrent or residual disease, and 3 are alive and free of disease. This contrasts with 3 dead, 6 with recurrent or residual disease, and 22 with total tumour resolution following primary therapy in the group with an adequate nutritional status. We accept, however, that a minimum period of 20 months is required to be statistically confident of disease-free survival following treatment .
